Hospitals’ Next Margin Lever, AI’s Trust Gap, Healthcare M&A

Good morning, ! Healthcare’s next margin story is starting to look less like a volume game—and more like an execution game.

This week, we look at why labor productivity is emerging as hospitals’ biggest margin lever, how consumers are adopting AI in healthcare faster than systems can build trust around it, and why healthcare M&A is active again—but still avoiding the biggest bets.

Know someone who would love this? Pass it along—they’ll thank you later! Here’s the link.

Join PE150 and Caplink for our AI & Data Insight Breakfast in London. Register here.

DATA DIVE

The Hospital Margin Reset: AI, Labor and the KPIs That Will Define the Next 3 Years

Hospital economics are shifting from volume recovery to operating execution. Healthcare150’s microsurveys show 29% of respondents now rank operating margin as the most important hospital KPI, ahead of bad debt at 26%, while admissions and outpatient volumes each attract 23%.

The more important signal sits underneath the margin number. When asked which lever offers the greatest potential for margin improvement over the next three years, 48% selected labor productivity, versus 31% for revenue cycle optimization and 21% for service line and patient mix.

That changes the hospital investment thesis. Incremental volume matters less if each additional patient requires expensive labor, creates collection risk, or adds limited contribution margin. The opportunity is increasingly about extracting more capacity and earnings from the existing operating base.

For executives and investors, the next diligence question is not simply whether margins are improving. It is whether those gains are supported by measurable productivity improvements, stronger collections, and better utilization of scarce clinical resources.

Bottom line: Hospital margin expansion is becoming an execution test, with workforce productivity emerging as the clearest lever. (More)

HEALTHTECH CORNER

AI Has Won Adoption. Now Comes Trust.

Consumers aren’t waiting for health systems to figure out AI. According to a new global survey from BCG, nearly 60% of consumers already use AI for personal health, from checking symptoms and interpreting test results to understanding treatment options.

The opportunity is quickly moving beyond information. Consumers increasingly expect AI to play a larger role in their care, while 16% already know their clinicians use AI—most commonly to review test results and suggest potential diagnoses or treatments.

But adoption is running ahead of trust. Privacy and data security remain consumers’ biggest concerns, alongside the reliability of AI-generated advice and whether recommendations are sufficiently personalized.

Bottom line: The next battleground in healthtech may not be convincing patients to use AI—they already are. It will be building the trusted infrastructure that connects AI with clinical data, provider workflows, and eventually healthcare transactions. For health systems and startups, trust could become as important a competitive moat as the model itself.

Read more

PRESENTED BY CAPLINK X PE 150

You’re invited: Where AI Meets Private Equity

Artificial intelligence has moved beyond experimentation. The real question for private equity firms is no longer whether to adopt AI, but how to turn it into measurable value across the investment lifecycle.

On November 18, PE150 and CapLink Group will host the AI / Data & Insight Private Capital Breakfast, an invitation-only gathering at London's May Fair Hotel that will bring together operating partners, deal teams, portfolio executives, and technology leaders to discuss what AI adoption actually looks like inside private equity.

The morning will feature three practitioner-led discussions:

• AI Into Value Creation — How leading firms are transforming AI from dashboards into repeatable value creation playbooks across portfolio companies.

• AI Across the Investment Lifecycle — Practical applications spanning sourcing, due diligence, investment decisions, and portfolio management.

• Building the AI-Enabled Private Equity Firm — The operating models, data strategies, and organizational capabilities required to scale AI successfully.

Interested in attending? Register or request the full agenda here.

Interested in sponsoring? Email [email protected] 

COMPETITIVE LANDSCAPE SNAPSHOT

TREND TO WATCH

Healthcare M&A Is Back, But Bigger Deals Are Missing

Healthcare deal activity in 1H26 is heavily concentrated at the lower end of the market. Transactions below $25M represent 45% of total deal volume, while another 39% sits between $25M and $499M.

At the other end, large-cap transactions remain scarce. Deals between $1B and $2.4B account for just 5% of activity, while transactions above $2.5B represent 0%.

The signal is less about weak appetite for healthcare assets and more about where buyers are willing to take risk. Smaller acquisitions require less financing, reduce integration exposure, and allow strategics and sponsors to add capabilities without committing to transformational transactions.

Why it matters: For healthcare executives and investors, the current market favors tuck-ins, carve-outs, and smaller platform acquisitions over blockbuster consolidation. If financing conditions improve, the real inflection point will be whether this active lower-middle market begins translating into larger deal sizes.

Bottom line: Healthcare M&A is moving, but capital is still choosing precision over scale. (More)

INTERESTING ARTICLES